Correction to "Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome"
- PMID: 34039656
- DOI: 10.1124/jpet.119.262238err
Correction to "Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome"
Erratum for
-
Comments on "Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome".J Pharmacol Exp Ther. 2021 Jun;377(3):369. doi: 10.1124/jpet.120.000426. J Pharmacol Exp Ther. 2021. PMID: 34039655 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
